Director Shan Yanan files Form 3 for Park Ha Biological (BYAH)

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. director Shan Yanan has filed an initial Form 3 insider ownership report. The available data shows no reported transactions or derivative positions, and no share holdings are detailed in this snapshot of the filing.

Key Terms

Form 3, reporting person, ten percent owner

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Shan Yanan""

ten percent owner regulatory

""is_ten_percent_owner": 0"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shan Yanan

(Last) (First) (Middle)

NO. 233 ZHENFA ROAD, SHUOFANG

LIANGXI DISTRICT

(Street)

WUXI 214000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2024

3. Issuer Name and Ticker or Trading Symbol
Park Ha Biological Technology Co., Ltd. [ BYAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Shan Yanan	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Park Ha Biological (BYAH) Form 3 for Shan Yanan disclose?

The Form 3 filing lists director Shan Yanan as a reporting person for Park Ha Biological Technology Co., Ltd. In the provided data, there are no reported transactions, holdings, or derivative positions, making this a purely administrative initial ownership report.

Are there any share purchases or sales in the BYAH Form 3 for Shan Yanan?

No transactions are shown for Shan Yanan in this Form 3 snapshot. The transaction summary indicates zero buy, sell, acquire, dispose, and derivative transactions, suggesting the filing only establishes reporting status without recording any insider trading activity.

Does the Park Ha Biological (BYAH) Form 3 show any derivative securities for Shan Yanan?

The data provided lists an empty derivativeSummary, indicating no options, warrants, or other derivative positions are detailed for Shan Yanan. This reinforces that the filing segment available is a basic initial ownership report without complex instruments.

What insider role does Shan Yanan have at Park Ha Biological (BYAH)?

The Form 3 data identifies Shan Yanan as a director of Park Ha Biological Technology Co., Ltd. They are not flagged as an officer or ten percent owner in this snapshot, so the filing focuses on director-level reporting obligations.

Why is a Form 3 filed for Park Ha Biological (BYAH) and Shan Yanan?

Form 3 is used to establish an insider’s initial ownership status. For Park Ha Biological, director Shan Yanan is being recorded as a reporting person. The excerpt shows no share counts or trades, highlighting the filing’s administrative nature.